OTC · Drug Manufacturers - Specialty & Generic

China Shineway Pharmaceutical Group Limited (CSWYF) Stock

$1.00 +0.00% OTC: CSWYF Healthcare

China Shineway Pharmaceutical Group Limited functions as an investment holding company, primarily engaged in the development, manufacturing, and commercialization of traditional Chinese medicines. Its operations span across the People's Republic of China and Hong Kong.

Valuation

MetricValue
Price$1.00
Market Cap$758.42M
P/E Ratio5.76
P/B Ratio0.67
P/S Ratio1.74
EPS (TTM)$0.17
52-Week High$1.00
52-Week Low$0.93
Dividend Yield12.00%

Financials & Margins

MetricValue
ROE11.97%
ROA8.81%
ROCE8.25%
Gross Margin72.28%
Operating Margin21.75%
Net Margin30.30%
Debt/Equity0.04
Current Ratio3.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.2B$4.0B$32.0B$3.8B$3.1B
Operating Profit$526.0M$728.0M$6.9B$843.0M$718.0M
Net Profit$557.0M$737.0M$972.0M$840.0M$950.0M
EPS$0.74$0.96$1.28$1.11$1.26
Op Margin16.6%18.1%21.6%22.3%22.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$7.2B$8.1B$9.6B$10.0B$10.8B
Total Liabilities$1.3B$1.8B$2.5B$2.6B$2.7B
Cash$4.2B$5.0B$41.7B$6.1B$7.2B
Borrowings$15.0M$7.0M$2.1B$347.0M$335.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$765.0M$1.2B$996.0M$963.0M$1.2B
Investing Cash Flow$303.0M$-177.0M$-194.0M$-412.0M$24.0M
Financing Cash Flow$-14.0M$-2.0M$-11.0M$-15.0M$-15.0M
Net Cash Flow$263.0M$821.0M$863.0M$251.0M$1.0B
Free Cash Flow$673.0M$1.1B$852.0M$823.0M$974.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.46
EV / EBITDA-1.70
FCF Yield19.49%
Quick Ratio3.43
Interest Coverage119.67
Return 1Y120.56%
Return 3Y762.76%
Return 5Y—

Ownership

Insiders Held66.31%
Institutions Held4.59%
Institutions Float Held13.62%
Institutional HolderSharesReport Date
iShares, Inc.-iShares Core MSCI Emerging Markets ETF5,322,0002026-05-31
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund3,929,8542026-04-30
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd3,675,8852026-04-30
DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT.2,524,0002026-04-30
Dimensional Emerging Markets Value Fund1,660,0002026-04-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited functions as an investment holding company, primarily engaged in the development, manufacturing, and commercialization of traditional Chinese medicines. Its operations span across the People's Republic of China and Hong Kong. The company's diverse product portfolio includes contemporary Chinese medicines, supplied in formats such as soft capsules, granules, and injections, alongside traditional Chinese medicine (TCM) Formula Granules. These offerings target a wide array of therapeutic fields, including cardiovascular and cerebrovascular health, anti-viral applications, orthopedic care, pediatric medicine, women's health, and digestive system disorders. Beyond pharmaceuticals, the company also participates in the trading of agricultural goods. Established in 2004, China Shineway Pharmaceutical Group Limited has its headquarters situated in Shijiazhuang, PRC, and operates as a subsidiary of Forway Investment Limited.

China Shineway Pharmaceutical Group Limited is headquartered in CN.

China Shineway Pharmaceutical Group Limited (CSWYF) stock trades at $1.00 with a market capitalization of $758.42M. The stock is valued at a price-to-earnings (P/E) ratio of 5.76, price-to-book of 0.67, price-to-sales of 1.74. Over the past 52 weeks the stock has ranged between $0.93 and $1.00, and currently trades at its 52-week high. It pays a dividend yielding 12.00%.

On profitability, China Shineway Pharmaceutical Group Limited generates a return on equity (ROE) of 11.97%, return on capital employed of 8.25%, an operating margin of 21.75%, a net profit margin of 30.30%.

Official website: www.shineway.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides